sess the effects ofweight reduction on metabolic control, energy production rate, and cardiovascular risk factors. During the 3 mo of follow-up the mean body weight decreased from 101.0 ± 7.2 (j ± SEM) to 87.2 ± 5.5 kg (p < 0.001).
Basal energy production rate (kJ/min) decreased by 8.5%. Fasting blood glucose declined from 12.3 ± 0.4 to 10.5 ± 0.7 mmol/L(p < 0.05) but mean diurnal glucose and glycosylated hemoglobin A1 did not change significantly.
Serum total cholesterol was decreased at 2 wk but at 3 mo it did not differ significantly from the baseline value. A marked reduction was observed in serum triglycerides after 3 mo (4.57 ± 1.0 vs 2. 18 ± 0.26 mmol/L, p A significant decline was found in both systolic (152 ± 6 vs 1 33 ± 3 mm Hg, p = 0.004) and diastolic blood pressure (92 ± 3 vs 8 1 ± 3 mm Hg, p = 0.007).
There was no evidence oflinoleic acid deficiency after this diet. Am J Clin Nuir l990;5 1:768-73.
Introduction
Very-low-calorie diets (VLCDs) have been increasingly used in the treatment of severe obesity
( 1 , 2). Formerly, some of these diets were considered to be dangerous, and several deaths related to liquid-protein modified fasting were reported in the 1970s(l, 2). These were principally ascribed to inadequate protein intake and electrolyte disturbances leading to degenerative changes of myocardium, prolonged QT interval, and ventricular fibrillation (3) (4) (5) In this study the weight lost during the follow-up was directly correlated to the initial body weight.
In addition to the increased fatness, the lean body mass is also increased in obesity (30, 3 1). Because the lean body mass is the most important determinant of basal energy expenditure or energy production rate (32) this can explain the higher energy production rate and greater weight loss found in the more obese subjects in the present study. 
